There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The activation of the clotting-fibrinolytic system in cancer patients is common and
represents an unfavorable clinical sign. D-dimer (DD) is a sensitive marker of fibrinolysis.